Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

In most countries worldwide, pneumococcal conjugate vaccines have been included in the infant immunization program, resulting in a significant reduction in the burden of pneumococcal disease in children and adults. Shifting serotype distribution due to the indirect effect of infant vaccination with...

Descripción completa

Detalles Bibliográficos
Autores principales: Buchwald, Ulrike K., Andrews, Charles P., Ervin, John, Peterson, James T., Tamms, Gretchen M., Krupa, David, Ajiboye, Patrick, Roalfe, Lucy, Krick, Andrea L., Sterling, Tina M., Wang, Meihua, Martin, Jason C., Stek, Jon E., Kohn, Melvin A., Folaranmi, Temitope, Abeygunawardana, Chitrananda, Hartzel, Jonathan, Musey, Luwy K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475587/
https://www.ncbi.nlm.nih.gov/pubmed/34019468
http://dx.doi.org/10.1080/21645515.2021.1888621

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475587/
https://www.ncbi.nlm.nih.gov/pubmed/34019468
http://dx.doi.org/10.1080/21645515.2021.1888621

Ejemplares similares